Biotech Aytu BioPharma Announces Highest Weekly Adzenys XR-ODT(R) Prescriptions Generated Since Inception of RxConnect November 30, 2022
Biotech Aeglea BioTherapeutics Appoints Jeffrey M. Goldberg as Chief Executive Officer November 30, 2022
Biotech Aridis Announces a Key Milestone of Closing of Patient Enrollment in the Phase 2a Study of AR-501 in Cystic Fibrosis Patients November 30, 2022
Biotech CTI BioPharma to Present at the JMP Securities Hematology and Oncology Summit November 30, 2022
Biotech SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Eiger BioPharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 9, 2023 – (NASDAQ: EIGR) November 30, 2022